利夫妥注射液

Country: Taiwan

Language: Chinese

Source: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

Active ingredient:

SODIUM BISULFITE (EQ TO SODIUM HYDROGEN SULFITE);;FRUCTOSE (LAEVULOSE);;MAGNESIUM CHLORIDE HEXAHYDRATE (EQ TO MAGNESIUM CHLORIDE 6H2O);;LACTIC ACID;;POTASSIUM PHOSPHATE ( eq to POTASSIUM PHOSPHATE DIBASIC);;SODIUM HYDROXIDE;;POTASSIUM CHLORIDE;;SODIUM CHLORIDE

Available from:

信東生技股份有限公司 桃園市桃園區介壽路２２號 (43211700)

ATC code:

B05BA10

Pharmaceutical form:

注射劑

Composition:

MAGNESIUM CHLORIDE HEXAHYDRATE (EQ TO MAGNESIUM CHLORIDE 6H2O) (4012001550) 0.30498MG; POTASSIUM CHLORIDE (4012001800) 1.26735MG; SODIUM CHLORIDE (4012002100) 0.2338MG; FRUCTOSE (LAEVULOSE) (4020000600) 100MG; POTASSIUM PHOSPHATE ( eq to POTASSIUM PHOSPHATE DIBASIC) (5612001900) 0.26127MG; SODIUM BISULFITE (EQ TO SODIUM HYDROGEN SULFITE) (6400000600) 0.41628MG; LACTIC ACID (9200005300) 2.07184MG; SODIUM HYDROXIDE (9600028200) 0.68017MG

Units in package:

瓶裝;;盒裝

Class:

製　劑

Prescription type:

限由醫師使用

Manufactured by:

信東生技股份有限公司 桃園市桃園區豐林里介壽路２２號 TW

Therapeutic area:

combinations

Therapeutic indications:

取代含有葡萄糖或轉化糖液劑之治療及其他非經口的水、電解質之補給

Product summary:

有效日期: 2024/12/16; 英文品名: LEFRUTOSE INJ. "S.T."

Authorization date:

1987-12-16